studies and other
properties using a partially purified preparation.
Biochim. Biophys. Acta, 321, 197-209 (1973).
5. Prus, K., and Wallin, M., Characterization of acid
and alkaline phosphatase activity
studies and other
properties using a partially purified preparation.
Biochim. Biophys. Acta, 321, 197-209 (1973).
5. Prus, K., and Wallin, M., Characterization of acid
and alkaline phosphatase activity
P NP_002098.1 y y y
321 HDAC-1 H3284 3065 HDAC1 P NP_004955.2 y y n/d
322 HDAC-1 H6287 3065 HDAC1 M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP
P NP_002098.1 y y y
321 HDAC-1 H3284 3065 HDAC1 P NP_004955.2 y y n/d
322 HDAC-1 H6287 3065 HDAC1 M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP
pharmacological characteristics. ■
References:
Ito, K ., et al . 2007 . J. Pharmacol. Exp. Therap. 321, 1 .
Medina-Tato, D .A ., et al . 2007 . Immunology 121, 448 .
Leslie, N .R . 2006 . Antioxid. Redox
P NP_002098.1 y y y
321 HDAC-1 H3284 3065 HDAC1 P NP_004955.2 y y n/d
322 HDAC-1 H6287 3065 HDAC1 M NP_004955.2 y y n/d
323 HDAC-2 H3159 3066 HDAC2 P NP_001518.3 y y n/d
324 HDAC-2 H2663 3066 HDAC2 M NP
poorly-differentiated
adenocarcinoma, stained with
anti-phosphotyrosine, clone 4G10
(Cat. No. 05-321) at 10 µg/mL.
EGF treated A431 cells that are triple
stained with anti-Phosphotyrosine, clone
4G10
REFERENCES
1. Grossman, T. H., Kawasaki, E. S.,
Punreddy, S. R., and Osburne, M. S.
(1998) Gene 209, 95–103
2. Pan, S. and Malcolm, B. A. (2000)
BioTechniques 29, 1234–1238.
3. Le Grice, S. F. J., Matzura
n (20°C) = 1.3915 Certipur® 108962 209
Refractive index standard kit 2 Toluene / water, traceable to SRM from NIST and PTB n (20°C) = 1.4969 Certipur® 108961 209
Refractive index standard kit 3 1
NP_003633.1 P y y n/d
321 HDAC-1 H3284 3065, 433759 HDAC1,Hdac1 NP_004955.2,NP_032254.1 P y y y
322 HDAC-1 H6287 3065, 433759 HDAC1,Hdac1 NP_004955.2,NP_032254.1 M y y n/d
323 HDAC-2 H3159 15182, 3066 Hdac2
NP_003633.1 P y y n/d
321 HDAC-1 H3284 3065, 433759 HDAC1,Hdac1 NP_004955.2,NP_032254.1 P y y y
322 HDAC-1 H6287 3065, 433759 HDAC1,Hdac1 NP_004955.2,NP_032254.1 M y y n/d
323 HDAC-2 H3159 15182, 3066 Hdac2
320 HAT1 ( Histone acetyltransferase 1) H7161 P y y n/d
321 HDAC-1 H3284 P y y y
322 HDAC-1 H6287 M y y n/d
323 HDAC-2 H3159 P y y y
324 HDAC-2 H2663 M y y y
325 HDAC-3 H6537 M y y
Chen, X. Biotechnol. J. 2017, 12, 1600671.
(16) Ozbolat, I. T.; Hospodiuk, M. Biomaterials 2016, 76, 321–343.
(17) Pereira, R. F.; Bártolo, P. J. J. Appl. Poly. Sci. 2015, 132, 42458.
(18) Tuan, R. S.; Boland
Chen, X. Biotechnol. J. 2017, 12, 1600671.
(16) Ozbolat, I. T.; Hospodiuk, M. Biomaterials 2016, 76, 321–343.
(17) Pereira, R. F.; Bártolo, P. J. J. Appl. Poly. Sci. 2015, 132, 42458.
(18) Tuan, R. S.; Boland
PTB n (20°C) = 1,3915 Certipur® 108962 209
Índice de refracción, patrón, kit 2 Tolueno/agua, trazable a SRM de NIST y PTB n (20°C) = 1,4969 Certipur® 108961 209
Índice de refracción, patrón, kit 3